by Michelle Ly | Feb 14, 2011
In previous posts, I discussed the use of cell therapy, specifically the application of allogenic or autologous hematopoietic stem cells (HSCs), as a way to repopulate blood cell lineages to normal levels post-treatment in patients suffering from certain types of...
by David Kent | Jan 19, 2011
Banned from receiving federal funds in 2004 by the Bush administration, human embryonic stem cell research was recently embraced by the Obama administration in March 2009 — sort of, anyway. As many readers are no doubt aware, U.S. courts are currently embroiled...
by Ubaka Ogbogu | Jan 4, 2011
In March 2009, in his remarks at the signing of an Executive Order to reverse the Bush-era stem cell research funding restrictions, President Obama directed John P. Holdren, Director of the Office of Science and Technology Policy, to “develop a strategy for restoring...
by Ubaka Ogbogu | Dec 16, 2010
President Obama’s Commission on the Study of Bioethical Issues today released a report of its ethical investigation and recommendations for oversight of the emerging field of synthetic biology. The report responds to a charge to the Commission issued by the President...
by Ubaka Ogbogu | Sep 10, 2010
The US Court of Appeals in Washington DC yesterday suspended a recent temporary injunction issued by a federal district judge against the use of federal funds for hESC research. Read my earlier post on the injunction. The suspension is temporary, and is intended to...
Comments